account_balance
Investment manager · 13F filer · SEC CIK 2050709
Squadron Capital Management LLC
Reported value$292Mas of Jun 30, 2026
Positions34 17 new, 13 sold out
Top 10 weight73%RLMD alone is 17%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
RLMD
Relmada Therapeutics Inc
17.4%Trimmed
CCCC
C4 Therapeutics Inc
11.5%Added
COGT
Cogent Biosciences Inc
11.5%Added
KOD
Kodiak Sciences Inc
6.7%Added
RLAY
Relay Therapeutics Inc
6.2%Added
ZNTL
Zentalis Pharmaceuticals Inc
6.1%
EWTX
Edgewise Therapeutics Inc
4.0%Trimmed
MAZE
Maze Therapeutics Inc
3.4%Added
IVA
Inventiva SA
3.2%Added
ANL
Adlai Nortye Ltd
3.0%Trimmed
24 others
27.0%
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed